News

Search:

Does Advisory Committee Transparency Lead to Better Regulatory Decision Making?

0 Likes

The US Food and Drug Administration (FDA) often courts controversy with its decisions to approve or deny new therapies. In the wake of some high-profile scandals in the past decade, the agency has Read More...

Tags:

AdComm

Advisory Committee

COI

Conflict of Interest

FDA

Regulatory

Transparency

Vioxx

Merck Settles Vioxx Criminal Charges With US for $322 Million

0 Likes

US pharmaceutical manufacturer Merck & Co. has settled criminal charges over the company’s marketing of its painkiller drug Vioxx, reports Bloomberg.Merck will pay a $321.6 million criminal fine after Read More...

Tags:

$322 Million

Arthritis

Charges

Criminal

Department of Justice

FDA

Illegal

Merck

Rheumatoid Arthritis

Vioxx

NBC Investigation 'Raises Questions About Lax Regulatory Oversight'

0 Likes

An investigation by Dateline NBC has found that clinical trial compensation in India is often driving economically disadvantaged patients to enroll in the trials regardless of the risks to their own Read More...

Tags:

Clinical Trials

Dateline

FDA

Gulhati

Hansen

India

Indian

Kessler

NBC

Vioxx

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

China's SFDA Becomes CFDA amidst Consolidation of Power and New Leadership 25 March 2013
FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

Does Advisory Committee Transparency Lead to Better Regulatory Decision Making?

Merck Settles Vioxx Criminal Charges With US for $322 Million

NBC Investigation 'Raises Questions About Lax Regulatory Oversight'

Get RF Today